Crossmark

Retina-specific laminin-based generation of photoreceptor progenitors from human pluripotent stem cells under xeno-free and chemically defined conditions

Crossref DOI link: https://doi.org/10.1038/s41596-025-01142-y

Published Online: 2025-02-25

Published Print: 2025-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tan, Wei Sheng

Lai, Yixin

Chung, Yingying

Adusumalli, Swarnaseetha

Lee, Xin Yi

Tryggvason, Karl

Tay, Hwee Goon https://orcid.org/0000-0002-5418-5149
Funding

Funding for this research was provided by:

MOH | National Medical Research Council (NMRC/OFYIRG/0042/2017, NMRC/STaR/0010/2012, MOH-000052, MOH-STaR18May-0001, NMRC/CIRG/1415/2014)
License Information

Text and Data Mining valid from 2025-02-25

Version of Record valid from 2025-02-25
More Information

Article History

Received: 21 August 2024

Accepted: 7 January 2025

First Online: 25 February 2025

Competing interests

: H.G.T. is co-founder of Alder Therapeutics. K.T. is co-founder of Alder Therapeutics and BioLamina. The remaining authors declare no competing interests.

Document is current

Any future updates will be listed below